文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

大型手术中非侵入性血流动力学监测检测低血容量:林格液、5%白蛋白或20%白蛋白作为输注液体的随机临床试验事后分析

Detection of hypovolemia by non-invasive hemodynamic monitoring during major surgery using Ringer´s solution, 5% albumin, or 20% albumin as infusion fluid: a post-hoc analysis of a randomized clinical trial.
PubMed 文献 · Crit Care · 2025-03-23
一句话结论不同输液类型下PPV、PVI、CO对低血容量(>500 mL)的检测能力不同,非侵入性监测识别低血容量仍具挑战且预测值低。

这项单中心随机对照试验事后分析纳入42例大型手术出血患者,随机接受5%白蛋白(12 mL/kg)或20%白蛋白(3 mL/kg)30分钟内输注并辅以乳酸林格液按1:1补充失血,或单用林格液按3:1补充。结果显示单用林格液组出现轻度低血容量(平均313 mL)、平均动脉压下降、心率增快、PPV升高及血管加压药需求增加;5%和20%白蛋白组扩容更有效,表现为平均循环充盈压更高、PPV不变或下降。ROC曲线提示,5%白蛋白时PPV、林格液时PVI、20%白蛋白时CO可较准确检测>500 mL的低血容量,但总体预测值低。

要点

  • 单用林格液(3:1)复苏导致轻度低血容量(平均313 mL),伴MAP下降、HR增快、PPV升高和血管加压药需求增加。
  • 5%白蛋白(12 mL/kg)和20%白蛋白(3 mL/kg)扩容更有效,表现为平均循环充盈压更高、5小时观察期内PPV不变或下降。
  • 20%白蛋白增加体循环血管阻力和静脉回流阻力。
  • 低血容量>500 mL的检测:5%白蛋白时PPV准确,林格液时PVI可靠,20%白蛋白时CO有指示作用。
  • 非侵入性血流动力学监测识别低血容量仍具挑战性,预测值低。

适用人群与场景

  • 大型手术中发生出血并接受液体复苏的患者(42例,单中心随机对照试验事后分析)

处置流程与药物剂量

  • 5%白蛋白组:12 mL/kg,30分钟内输注,并用乳酸林格液按1:1比例补充失血。
  • 20%白蛋白组:3 mL/kg,30分钟内输注,并用乳酸林格液按1:1比例补充失血。
  • 林格液组:单用林格液,按3:1比例补充失血。

研究设计与关键结果

  • 单中心随机对照试验事后分析,42例大型手术出血患者,随机接受5%白蛋白(12 mL/kg)或20%白蛋白(3 mL/kg)30分钟输注并辅以乳酸林格液1:1补充失血,或单用林格液3:1补充。
  • 单用林格液组出现轻度低血容量(平均313 mL)、MAP下降、HR增快、PPV升高及血管加压药需求增加。
  • 5%和20%白蛋白组扩容更有效,表现为平均循环充盈压更高、5小时观察期内PPV不变或下降。
  • 20%白蛋白增加体循环血管阻力和静脉回流阻力。
  • ROC曲线提示:低血容量>500 mL仅在5%白蛋白时可由PPV准确检测,林格液输注时PVI可靠,20%白蛋白时CO可指示低血容量。
  • 非侵入性血流动力学监测识别低血容量仍具挑战性,预测值低。

证据类型、等级与局限

  • 证据类型:单中心随机对照试验的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,PPV、PVI和CO的趋势反映血管内容量变化,但其指示低血容量>500 mL的能力可能因输注液体选择而异。
  • 作者认为,使用非侵入性血流动力学监测识别低血容量仍具挑战性且预测值低。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Fluid loading with crystalloids is the conventional treatment of major hemorrhage but might tend to create fluid overload. We studied hemodynamic profiles of fluid replacement therapies during major surgical hemorrhage and compared the ability of pulse pressure variation (PPV), plethysmographic variation index (PVI), cardiac output (CO) and Guyton´s approach to detect hypovolemia.

METHODS: In this single center randomized controlled trial, fluid replacement therapy to treat hemorrhage in 42 patients was randomized to consist of either 5% albumin (12 mL/kg) or 20% albumin (3 mL/kg) over 30 min, both completed by Ringer lactate replacing blood loss in a 1:1 ratio, or Ringer solution alone in a 3:1 ratio. Measurements included CO, PPV, PVI, arterial and central venous pressures, heart rate (HR) and subsequent calculation of Guyton´s physiological parameters. CO was measured by an esophageal Doppler probe.

RESULTS: The Ringer-only fluid program resulted in slight hypovolemia (mean, 313 mL), decreased mean arterial pressure (MAP), increased HR, PPV values and vasopressor requirement. The 5% and 20% albumin programs were more effective in filling the vascular system, as evidenced by higher mean circulatory filling pressure and unchanged or decreased PPV over the 5 h observation period. The 20% albumin increased the systemic vascular resistance and the resistance to venous return. Receiver operating characteristics curves indicated that hypovolemia > 500 mL could only be accurately detected by PPV when 5% albumin was used, that PVI was reliable when Ringer was infused, and that CO indicated the hypovolemia when 20% albumin was administered.

CONCLUSIONS: The trends in PPV, PVI, and CO reflected the changes in intravascular volume, but how well they indicated hypovolemia > 500 mL may differ depending on the choice of infusion fluid. Identifying hypovolemia using non-invasive hemodynamic monitors remains challenging and associated with low predictive values.

TRIAL REGISTRATION NUMBER: NCT05391607, May 26, 2022.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Jardot F, Hahn RG, Huber M, et al. Detection of hypovolemia by non-invasive hemodynamic monitoring during major surgery using Ringer´s solution, 5% albumin, or 20% albumin as infusion fluid: a post-hoc analysis of a randomized clinical trial. Crit Care. 2025. PMID: 40122881. doi:10.1186/s13054-025-05357-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。